Orange Ventures invests in French health-tech startup Biolevate
Orange Ventures invested in French health-tech startup Biolevate in its latest financing round, taking a minority stake. Deal targets life sciences automation, aiming to speed drug development workflows using Biolevate’s agentic AI platform. Orange Business will partner with Biolevate, combining its technology with Eno